Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1/2 9Phase 1 8Phase 3 3Phase EARLY_PHASE1 1

Status

Completed 11Active not recruiting 10Recruiting 8Terminated 3Withdrawn 1Not yet recruiting 1

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1Carcinoma, Renal Cell 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Immunoglobulin G × Clear all
NCT00946712 2023-05-23

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

SWOG Cancer Research Network

Phase 3 Terminated
1,333 enrolled 22 charts
Thoracic

Adenocarcinoma of Lung

NCT01198158 2019-03-06

Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy

National Cancer Institute (NCI)

Phase 3 Terminated
77 enrolled 11 charts
Genitourinary

Carcinoma, Renal Cell

NCT00324987 2017-09-14

S0502

National Cancer Institute (NCI)

Phase 3 Terminated
12 enrolled 13 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡